About this trial
When a newborn is diagnosed with tachyarrhythmia, they are generally started on medical therapies, most commonly a beta-blocker, while being observed in an inpatient setting. In most academic institutions, current practice is to provide parental teaching on use of a stethoscope to auscultate their child when there is suspicion for distress, in addition to requiring cardiopulmonary resuscitation (CPR) classes. Fortunately, newer technologies have emerged that allow for capture of cardiac rhythm that may provide a buffer between the infant and the emergency room.
Eligibility criteria
Qualifiers
Age <1 year
No previous diagnosis of arrhythmia
Parent/caregiver can provide informed consent
Parent/caregiver can speak and understand simple English
Disqualifiers
Age ≥ 1 year
Patient has a pacemaker or implantable cardioverter defibrillator (ICD)
Parent/caregiver is unwilling or unable to provide informed consent
Parent/caregiver is unable to speak and understand English
Trial design
Treatments tested in this trial
- Eko Duo electronic stethoscope
- CORE 500 electronic stethoscope
Treatment groups
Sponsors and collaborators
Virginia Commonwealth University
Lead sponsor
Eko Devices, Inc.
Collaborator